The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Zitrease Allergy 10 mg Film-coated tablets



Bluefish Pharmaceuticals ABPA1436/042/001

Main Information

Trade NameZitrease Allergy 10 mg Film-coated tablets
Active SubstancesCetirizine hydrochloride
Dosage FormFilm-coated tablet
Licence HolderBluefish Pharmaceuticals AB
Licence NumberPA1436/042/001

Group Information

ATC CodeR06AE Piperazine derivatives
R06AE07 cetirizine

Status

License statusAuthorised
Licence Issued06/02/2004
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of LicenceRetail sale through pharmacies only and promotion to the public subject to the following restrictions: maximum pack size 10 unit dosage forms, maximum strength: 10 mg, maximum daily dose: 10 mg.
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0088-002-003
Interchangeable List DocumentPDF of Interchangeable List
« Back